resource library
Understanding Total Pipeline Inventory
IntegriChain quantifies total pipeline inventory through its DNA: Measurement of Retail Inventory™ (MRI) analytic. MRI is the foremost measure of downstream inventory (retail, mail, LTC and institution) used by leading pharmaceutical companies to validate their pipeline inventory reserves. The finance and forecasting teams for several of the world’s largest pharmaceutical brands rely on MRI and IntegriChain’s DNA platform to improve channel visibility and sales reporting accuracy.
Registration Form
Please provide us with your contact details so that we can serve your needs efficiently. Thank you.Login
- The Strategic Value of Pharmacy: Best Practices(.pdf)
- The Strategic Value of Pharmacy(.pdf)
- Success Story: Returns on Promotions(.pdf)
- Returns Reduction Services(.pdf)
- Pharmacy Targeting Services(.pdf)
- Demand Verification Checkup(.pdf)
- Master Data Services(.pdf)
- Case Study: Analyzing Returns with DNA Platform(.pdf)
- DNA: Channel Insight(.pdf)
- DNA: Chargeback Validation(.pdf)
- DNA: Measurement of Retail Inventory(.pdf)
- Leading the Transformation of the Pharmaceutical Marketplace(.pdf)
- DNA: Dynamic NextGen Analytics--Unlocking the Value of Direct Data(.pdf)
- Understanding Total Pipeline Inventory(.pdf)
- Moving Your Data Up the Enterprise Value Chain(.pdf)